Cholesterol Phenylacetate |
Catalog No.GD06945
One-Click Copy Product Info
|
Cholesterol Phenylacetate는 스테로이드핵의 B링에 이중 결합이 존재하고 페닐아세테이트 부사슬에 추가적인 이중 결합이 있는 스테롤 에스테르이다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 33998-26-4
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Cholesterol Phenylacetate는 스테로이드핵의 B링에 이중 결합이 존재하고 페닐아세테이트 부사슬에 추가적인 이중 결합이 있는 스테롤 에스테르이다. Cholesterol Phenylacetate는 공기를 산소원으로 하고 트랜스-디옥소루테늄(VI)테트라메시틸포르피린을 촉매로 사용해서 에폭시화 반응에 노출되었다. 결과는 Cholesterol Phenylacetate가 스테로이드핵의 5,6 위치에서 선택적으로 에폭시화 반응을 겪었다는 것을 보여주었다. 에폭시화 반응은 매우 지역 선택적이었고 2시간 내에 주로 5,6β-에폭시화물을 생성해서 수율이 88%였다[1].
References:
[1] Tavares M, Ramasseul R, Marchon J C. Regioselective epoxidation by air of sterol esters bearing several double bonds using a ruthenium porphyrin cataltyst. Catalysis Letters 4 (1990) 163-168.
| Cas No. | 33998-26-4 | SDF | |
| Formula | C35H52O2 | M.Wt | 504.786 |
| Solubility | Storage | Store at RT | |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.981 mL | 9.9052 mL | 19.8104 mL |
| 5 mM | 396.2 μL | 1.981 mL | 3.9621 mL |
| 10 mM | 198.1 μL | 990.5 μL | 1.981 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)